Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

San Diego-based Illumina, a global leader in genomic sequencing technology ... the industry alongside the company with every product launch. That turning point is one of the reasons it was ...

which is a competitor to Illumina technology, like its mid-range NextSeq 2000 sequencer, and the forthcoming launch of Aviti24 that combines sequencing and cell characteristic mapping in a single ...

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

The IMCore of the UW Sensory Biology Center is pleased to announce the availability of an Illumina NextSeq 1000 sequencer. This equipment is purchased exclusively via an administrative supplement ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations. Hence, investors might consider investing in genomics stocks such as ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Illumina, Inc. engages in the development ... Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting.

[1] Examples are platforms developed by companies such as Roche Applied Science (454 Genome Sequencer FLX [GS FLX] System; CT, USA), Illumina (Genome Analyzer [GA] II; CA, USA), Life Technologies ...